Effectiveness of an annular closure device in a “real-world” population: stratification of registry data using screening criteria from a randomized controlled trial

Adisa Kuršumović, Stefan A Rath Department of Neurosurgery, Spinal Surgery and Interventional Neuroradiology, Donauisar Klinikum Deggendorf, Deggendorf, Germany Purpose: Increased focus has been put on the use of “‘real-world” data to support randomized clini...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kuršumović A, Rath SA
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/b6e09cdc51aa4638a8413ab11043b2b1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b6e09cdc51aa4638a8413ab11043b2b1
record_format dspace
spelling oai:doaj.org-article:b6e09cdc51aa4638a8413ab11043b2b12021-12-02T07:59:43ZEffectiveness of an annular closure device in a “real-world” population: stratification of registry data using screening criteria from a randomized controlled trial1179-1470https://doaj.org/article/b6e09cdc51aa4638a8413ab11043b2b12018-06-01T00:00:00Zhttps://www.dovepress.com/effectiveness-of-an-annular-closure-device-in-a-real-world-population--peer-reviewed-article-MDERhttps://doaj.org/toc/1179-1470Adisa Kuršumović, Stefan A Rath Department of Neurosurgery, Spinal Surgery and Interventional Neuroradiology, Donauisar Klinikum Deggendorf, Deggendorf, Germany Purpose: Increased focus has been put on the use of “‘real-world” data to support randomized clinical trial (RCT) evidence for clinical decision-making. The objective of this study was to assess the performance of an annular closure device (ACD) after stratifying a consecutive series of “real-world” patients by the screening criteria of an ongoing RCT. Materials and methods: This was a single-center registry analysis of 164 subjects who underwent limited discectomy combined with ACD for symptomatic lumbar disc herniation. Patients were stratified into two groups using the selection criteria of a pivotal RCT on the same device: Trial (met inclusion; n=44) or non-Trial (did not meet inclusion; n=120). Patient-reported outcomes, including Oswestry Disability Index (ODI) and visual analog scale (VAS) for leg and back pain, and adverse events were collected from baseline to last follow-up (mean: Trial – 15.6 months; non-Trial – 14.6 months). Statistical analyses were performed with significance set at p<0.05. Results: Patient-reported outcomes were not significantly different between groups at last follow-up (p≥0.15) and clinical success (≥15-point improvement in ODI score; ≥20-point improvement in VAS scores) was achieved in both the groups. Three non-Trial (2.5%) and three Trial (6.8%) patients experienced symptomatic reherniation (p=0.34). Rates of reoperation, ACD mesh dislocation/separation, and other radiographic findings were similar between groups (p=1.00). Conclusion: Outcomes with the ACD appeared advantageous in both the groups, particularly in comparison with historical reherniation rates reported in the same high-risk, large annular defect population. Stratification of this “real-world” series on the basis of RCT screening criteria did not result in significant between-group differences. These findings suggest that the efficacy of the ACD extends beyond the strictly defined patient population being studied in the RCT of this device. Furthermore, reducing the reherniation rate following lumbar discectomy has positive clinical and economic implications. Keywords: annular closure device, annular defect, discectomy, disc herniation, real-world evidenceKuršumović ARath SADove Medical PressarticleAnnular closure deviceAnnular defectDiscectomyDisc herniationReal-world evidenceMedical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol Volume 11, Pp 193-200 (2018)
institution DOAJ
collection DOAJ
language EN
topic Annular closure device
Annular defect
Discectomy
Disc herniation
Real-world evidence
Medical technology
R855-855.5
spellingShingle Annular closure device
Annular defect
Discectomy
Disc herniation
Real-world evidence
Medical technology
R855-855.5
Kuršumović A
Rath SA
Effectiveness of an annular closure device in a “real-world” population: stratification of registry data using screening criteria from a randomized controlled trial
description Adisa Kuršumović, Stefan A Rath Department of Neurosurgery, Spinal Surgery and Interventional Neuroradiology, Donauisar Klinikum Deggendorf, Deggendorf, Germany Purpose: Increased focus has been put on the use of “‘real-world” data to support randomized clinical trial (RCT) evidence for clinical decision-making. The objective of this study was to assess the performance of an annular closure device (ACD) after stratifying a consecutive series of “real-world” patients by the screening criteria of an ongoing RCT. Materials and methods: This was a single-center registry analysis of 164 subjects who underwent limited discectomy combined with ACD for symptomatic lumbar disc herniation. Patients were stratified into two groups using the selection criteria of a pivotal RCT on the same device: Trial (met inclusion; n=44) or non-Trial (did not meet inclusion; n=120). Patient-reported outcomes, including Oswestry Disability Index (ODI) and visual analog scale (VAS) for leg and back pain, and adverse events were collected from baseline to last follow-up (mean: Trial – 15.6 months; non-Trial – 14.6 months). Statistical analyses were performed with significance set at p<0.05. Results: Patient-reported outcomes were not significantly different between groups at last follow-up (p≥0.15) and clinical success (≥15-point improvement in ODI score; ≥20-point improvement in VAS scores) was achieved in both the groups. Three non-Trial (2.5%) and three Trial (6.8%) patients experienced symptomatic reherniation (p=0.34). Rates of reoperation, ACD mesh dislocation/separation, and other radiographic findings were similar between groups (p=1.00). Conclusion: Outcomes with the ACD appeared advantageous in both the groups, particularly in comparison with historical reherniation rates reported in the same high-risk, large annular defect population. Stratification of this “real-world” series on the basis of RCT screening criteria did not result in significant between-group differences. These findings suggest that the efficacy of the ACD extends beyond the strictly defined patient population being studied in the RCT of this device. Furthermore, reducing the reherniation rate following lumbar discectomy has positive clinical and economic implications. Keywords: annular closure device, annular defect, discectomy, disc herniation, real-world evidence
format article
author Kuršumović A
Rath SA
author_facet Kuršumović A
Rath SA
author_sort Kuršumović A
title Effectiveness of an annular closure device in a “real-world” population: stratification of registry data using screening criteria from a randomized controlled trial
title_short Effectiveness of an annular closure device in a “real-world” population: stratification of registry data using screening criteria from a randomized controlled trial
title_full Effectiveness of an annular closure device in a “real-world” population: stratification of registry data using screening criteria from a randomized controlled trial
title_fullStr Effectiveness of an annular closure device in a “real-world” population: stratification of registry data using screening criteria from a randomized controlled trial
title_full_unstemmed Effectiveness of an annular closure device in a “real-world” population: stratification of registry data using screening criteria from a randomized controlled trial
title_sort effectiveness of an annular closure device in a “real-world” population: stratification of registry data using screening criteria from a randomized controlled trial
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/b6e09cdc51aa4638a8413ab11043b2b1
work_keys_str_mv AT kursumovica effectivenessofanannularclosuredeviceinaldquorealworldrdquopopulationstratificationofregistrydatausingscreeningcriteriafromarandomizedcontrolledtrial
AT rathsa effectivenessofanannularclosuredeviceinaldquorealworldrdquopopulationstratificationofregistrydatausingscreeningcriteriafromarandomizedcontrolledtrial
_version_ 1718398744481759232